Efficacy and Safety of Luo-Fu-Shan Plaster in Patients With Rheumatoid Arthritis
NCT04884880 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 180
Last updated 2021-05-13
Summary
The aim of this study is to assess the efficacy and safety of Luo-Fu-Shan Plaster in patients with Rheumatoid Arthritis.
Conditions
- Arthritis, Rheumatoid
Interventions
- DRUG
-
Luo-Fu-Shan Plaster
Luo-Fu-Shan Plaster 10g,once daily,4 weeks
- DRUG
-
The placebo 10g
Placebo 10g,once daily,4 weeks
Sponsors & Collaborators
-
Guang'anmen Hospital of China Academy of Chinese Medical Sciences
lead OTHER
Principal Investigators
-
Jiang Quan, PhD · Guang'anmen Hospital
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- DOUBLE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Max Age
- 75 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2021-05-14
- Primary Completion
- 2021-12-31
- Completion
- 2022-04-30
Countries
- China
Study Locations
More Related Trials
-
Safety and Efficacy Study of Adalimumab in Adult Chinese Rheumatoid Arthritis Subjects Treated With Methotrexate
NCT00538902 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
A Study of TJ003234 in Rheumatoid Arthritis Patients
NCT04457856 ·Status: UNKNOWN ·Phase: PHASE1
-
Efficacy and Safety Study of KN019 in Rheumatoid Arthritis Patients With an Inadequate Response to Methotrexate
NCT04038970 ·Status: COMPLETED ·Phase: PHASE2
-
Fucoidan in the Treatment of Active Rheumatoid Arthritis
NCT07045896 ·Status: RECRUITING ·Phase: NA
-
Molecular Mechanism of Neutrophil Necroptosis and Its Roles in RA Pathogenesis
NCT02385331 ·Status: UNKNOWN
-
Study of Subcutaneous Golimumab in Chinese Patients With Active Rheumatoid Arthritis Despite Methotrexate Therapy
NCT01248780 ·Status: COMPLETED ·Phase: PHASE3
-
Modified Zhiwang Decoction Combined With Methotrexate in the Treatment of Early Rheumatoid Arthritis
NCT05508815 ·Status: UNKNOWN ·Phase: EARLY_PHASE1
-
A Study Investigating the Efficacy and Safety of BGB-45035 Versus Placebo in Adults With Moderate to Severe Active Rheumatoid Arthritis
NCT07100938 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
Efficacy and Safety of CDP870 Versus Placebo in the Treatment of the Signs and Symptoms of Rheumatoid Arthritis
NCT00548834 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy And Safety Of Tofacitinib In Chinese Subjects With Active Psoriatic Arthritis
NCT03486457 ·Status: COMPLETED ·Phase: PHASE3
-
Study of LW402 Tablets in Moderate to Severe Rheumatoid Arthritis
NCT06800157 ·Status: COMPLETED ·Phase: PHASE2
-
Assessment of the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Multiple Subcutaneous Injections of GenSci120 in Healthy Adult Participants in China.
NCT07040930 ·Status: RECRUITING ·Phase: PHASE1
-
A Clinical Study of TQH3821 Tablets in the Treatment of Treated Rheumatoid Arthritis
NCT05849727 ·Status: TERMINATED ·Phase: PHASE2
-
A Study Assessing the Efficacy and Safety of SM03 in Patients With Active Rheumatoid Arthritis Receiving MTX
NCT04312815 ·Status: UNKNOWN ·Phase: PHASE3
-
Tolerance, Pharmacokinetics and Preliminary Efficacy of T0001 in RA (Rheumatoid Arthritis)
NCT02481180 ·Status: TERMINATED ·Phase: PHASE1
-
A Phase II Trial of SHR-3045 Injection in Patients With Rheumatoid Arthritis
NCT07233655 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
A Study of GNC-038 Tetra-specific Antibody Injection in Patients With Rheumatoid Arthritis
NCT06857227 ·Status: RECRUITING ·Phase: PHASE1
-
Safety and Efficacy of ACZ885 in Adult Patients With Established Rheumatoid Arthritis
NCT00504595 ·Status: COMPLETED ·Phase: PHASE2
-
Comparative Study (Double-Blind) of MRA for Rheumatoid Arthritis (RA)
NCT00144521 ·Status: COMPLETED ·Phase: PHASE3
-
Efficacy of JAK STAT Pathways Inhibitors in Treatment of Patients With Rheumatoid Arthritis
NCT05788705 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
Efficacy, Tolerability and Safety Study in Rheumatoid Arthritis (0812-008)
NCT00542022 ·Status: COMPLETED ·Phase: PHASE2
-
Efficacy and Safety of Adalimumab in Adult Chinese Subjects With Active Ankylosing Spondylitis
NCT01114880 ·Status: COMPLETED ·Phase: PHASE3
-
A Phase Ⅰ Clinical Trial to Evaluate the Safety, Tolerance, Pharmacokinetics and Pharmacodynamics of SHR-3045 in Healthy Subjects
NCT06883695 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1
-
A Phase I Clinical Study of VC005 Tablets in Subjects With Rheumatoid Arthritis.
NCT05874622 ·Status: COMPLETED ·Phase: PHASE1
-
A Study of Rituximab (MabThera®/Rituxan®) in Patients With Rheumatoid Arthritis and Inadequate Response to Methotrexate
NCT00578305 ·Status: COMPLETED ·Phase: PHASE3